Shell Asset Management Co. Lowers Stock Position in Agilent Technologies, Inc. (NYSE:A)

Shell Asset Management Co. cut its stake in shares of Agilent Technologies, Inc. (NYSE:AGet Rating) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,718 shares of the medical research company’s stock after selling 232 shares during the quarter. Shell Asset Management Co.’s holdings in Agilent Technologies were worth $5,862,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the company. BlackRock Inc. increased its holdings in shares of Agilent Technologies by 7.1% during the third quarter. BlackRock Inc. now owns 27,472,617 shares of the medical research company’s stock valued at $4,327,761,000 after acquiring an additional 1,820,330 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Agilent Technologies by 38.8% during the third quarter. Wellington Management Group LLP now owns 8,057,215 shares of the medical research company’s stock valued at $1,269,255,000 after acquiring an additional 2,250,500 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Agilent Technologies by 0.4% during the third quarter. Geode Capital Management LLC now owns 5,762,262 shares of the medical research company’s stock valued at $905,618,000 after acquiring an additional 21,300 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Agilent Technologies by 155.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 3,978,462 shares of the medical research company’s stock worth $626,727,000 after buying an additional 2,423,618 shares in the last quarter. Finally, UBS Asset Management Americas Inc. increased its holdings in Agilent Technologies by 13.6% in the 3rd quarter. UBS Asset Management Americas Inc. now owns 2,471,288 shares of the medical research company’s stock worth $389,302,000 after buying an additional 296,787 shares in the last quarter.

Several equities research analysts recently commented on the company. SVB Leerink reduced their price objective on Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating for the company in a report on Wednesday, February 23rd. Bank of America reduced their price objective on Agilent Technologies from $179.00 to $160.00 and set a “buy” rating for the company in a report on Wednesday, February 23rd. Robert W. Baird dropped their target price on Agilent Technologies from $170.00 to $161.00 in a research report on Wednesday, February 23rd. Evercore ISI dropped their target price on Agilent Technologies from $170.00 to $155.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 23rd. Finally, Cowen dropped their target price on Agilent Technologies from $187.00 to $178.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 23rd. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Buy” and an average target price of $158.23.

NYSE A traded down $1.79 during trading hours on Friday, reaching $119.27. The company’s stock had a trading volume of 2,269,171 shares, compared to its average volume of 2,077,101. The firm’s 50-day moving average price is $130.86 and its 200-day moving average price is $143.53. The company has a quick ratio of 1.64, a current ratio of 2.19 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 1 year low of $117.24 and a 1 year high of $179.57. The company has a market capitalization of $35.83 billion, a price-to-earnings ratio of 30.27, a PEG ratio of 2.69 and a beta of 1.05.

Agilent Technologies (NYSE:AGet Rating) last released its quarterly earnings data on Tuesday, February 22nd. The medical research company reported $1.21 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.17 by $0.04. Agilent Technologies had a return on equity of 27.04% and a net margin of 18.70%. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.66 billion. During the same quarter in the previous year, the company posted $1.06 EPS. The company’s revenue was up 8.1% compared to the same quarter last year. Equities research analysts anticipate that Agilent Technologies, Inc. will post 4.86 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 27th. Stockholders of record on Tuesday, April 5th were given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend was Monday, April 4th. Agilent Technologies’s dividend payout ratio is currently 21.32%.

In other news, SVP Michael Tang sold 1,210 shares of the business’s stock in a transaction that occurred on Friday, March 18th. The stock was sold at an average price of $136.21, for a total transaction of $164,814.10. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

About Agilent Technologies (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.